Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

NCT02687490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Abraxane

Sponsor

Fudan University